Sepsis
336 results
1 - 100
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock- De‐escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock
- Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock
- Vancomycin for prophylaxis against sepsis in preterm neonates
- High‐volume haemofiltration for sepsis in adults
- Antibiotic regimens for suspected early neonatal sepsis
- Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates
- Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
- Corticosteroids for treating sepsis in children and adults
- Antibiotic regimens for early‐onset neonatal sepsis
- Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia
- N‐acetylcysteine for sepsis and systemic inflammatory response in adults
- Antibiotic regimens for late‐onset neonatal sepsis
- Antibiotic regimens for suspected late onset sepsis in newborn infants
- Recombinant human activated protein C for severe sepsis in neonates
- Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults
- Molecular assays for the diagnosis of sepsis in neonates: a diagnostic test accuracy review
- Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants
- Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock
- Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients
- Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
- Early versus late pre‐intensive care unit admission broad spectrum antibiotics for severe sepsis in adults
- Methods of preventing bacterial sepsis and wound complications after liver transplantation
- Beta lactam antibiotic monotherapy versus beta lactam‐aminoglycoside antibiotic combination therapy for sepsis
- One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates
- Umbilical cord antiseptics for preventing sepsis and death among newborns
- Antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections
- Catheter impregnation, coating or bonding for reducing central venous catheter‐related infections in adults
- Prophylactic versus selective antibiotics for term newborn infants of mothers with risk factors for neonatal infection
- Vitamin E supplementation for prevention of morbidity and mortality in preterm infants
- Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants
- Effects of antibiotic prophylaxis during labour on maternal and neonatal outcomes in women planning vaginal birth
- Skin antisepsis for reducing central venous catheter‐related infections
- Antimicrobial dressings for the prevention of catheter‐related infections in newborn infants with central venous catheters
- Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function
- Antibiotics for prelabour rupture of membranes at or near term: Cochrane systematic review
- Sealing procedures for preterm prelabour rupture of membranes
- Lactoferrin for the postoperative management of term neonates after gastrointestinal surgery
- Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants
- Vitamin A supplementation during pregnancy: Cochrane systematic review
- Probiotics for the postoperative management of term neonates after gastrointestinal surgery
- Inositol in preterm infants at risk for or having respiratory distress syndrome